PULSUS Group welcomes you to attend “2nd International Conference on Clinical Research and Case Reports” on February 05-06, 2021, at Paris, France. This focus on the theme “Scientific Advancement in Medication and Progression against Disorder in Clinical Research”. It expects to be one of the main International meetings for introducing novel and key advances in the fields of Clinical Research 2021. It additionally serves to encourage correspondence among specialists and professionals working in a wide assortment of logical territories with a typical enthusiasm for improving Clinical Research and Case Reports related techniques.
Clinical Research 2021 gathering includes Keynote presentations, Oral talks, and Poster presentations, Workshops, Symposium, Seminar and Exhibitions. Clinical Research 2021 is a worldwide review which will give a universal stage to the conversation of Clinical examination and preliminaries. This occasion assembles all the prominent people, educators, researchers, specialists, clinical experts, wellbeing laborers, experts, understudies, and industrialists everywhere throughout the world to trade their thoughts, investigates and their experiences. The main aim of this conference is to provide informative sessions on Clinical Research and Case Reports.
1. For Researchers and Faculty Members:
• Speaker Presentation
• Poster Display
• Symposium hosting (4-5-member team)
• Workshop organizing
2. For Universities, Associations & Societies:
• Association Partnering
• Collaboration proposals
• Academic Partnering
• Group Participation
3. For Students and Research Scholars:
• Poster Competition (Winner will get Best Poster Award)
• Young Researcher Forum (YRF Award to the best presenter)
• Student Attendee
• Group registrations
4. For Business Delegates:
• Speaker Presentations
• Symposium hosting
• Networking opportunities
5. For Product Manufacturers:
• Exhibitor and Vendor booths
• Sponsorships opportunities
• Marketing and Networking with clients
• Workshop organizing
Why to attend?
Clinical Research 2021 Conference is a multidisciplinary program with wide help people from around the globe focused on getting some information about clinical examination and its advances. This is your most obvious opportunity to accomplish the greatest cluster of individuals from Clinical Trials, Clinical Research and Epidemiology society that is from the academic network, clinical examination components, therapeutic gatherings, related affiliations, social requests and besides from government associations, pharmaceutical, biomedical and restorative device undertakings.
Clinical Research 2021 provides you a great opportunity to join with the explorer in Clinical Research congress. The most renowned speakers can discuss more about the advancement, updates and latest research works. It provides importance for the overall population about the significance of clinical trials in prevention, diagnosis and treatment of infection.
Who can attend?
- Clinical Research & Development
- Clinical Bioinformatics
- Clinical Nanotechnology
- Clinical Design/ Protocol Design/ Clinical Strategy
- Global Clinical Operations/ Clinical Outsourcing
- Biostatistics/Data management
- Clinical Associations
- Clinical research institutes
- Medical Directors
- Principal Investigators
- Clinical research professionals
- University Faculties
- Research Scholars
- Pharma/Biotech and Medical Device industries
Track 1: Innovations in Clinical Research
Clinical Research is a part of medicinal science that decides the wellbeing and adequacy of medications, gadgets, diagnostic products and regimens for human use. These might be utilized for avoidance, treatment, analysis or for diminishing indications of an infection. Clinical exploration is not quite the same as clinical practice. In clinical practice built up medicines are utilized, while in clinical examination proof is gathered to build up a treatment.
Clinical Research is witnessing some significant advancement in clinical trials strategies that may integrate idea of patient-basic clinical trials, automation of clinical trial supplies, and utilization of inventive encryption techniques like Block chain to guarantee information security, investigation of increasingly computerized advances among others. Besides, as new medicine examine and advancement has accomplished, the pharmaceutical business begins to focus on the output for new or elective drugs, for instance, ordinary Chinese prescription can useful for treating basic as well as complicated infections.
Track 1-1: Protocol development
Track 1-2: Herbal Drugs
Track 1-3: Structuring the Clinical Trials of the future
Track 1-4: Paperless Clinical Trials
Track 1-5: Advancement in Clinical Technologies
Track 1-6: Embracing the Clinical trial for the future
Track 2: Pharmacology in Clinical Research:
Pharmacology in Clinical Research is the science of drugs in humans and their optimal clinical use in patients. It carries the basic science of pharmacology, with an additional focus on the use of pharmacological studies and quantitative methods in the human patient’s population. It has a wide application from the disclosure of new objective molecules with the impacts of drug utilization in entire populations. Clinical Pharmacologists commonly have a severe medical and logical coaching that empowers them to assess proof and produce new information through all around structured clinical examinations. Clinical Pharmacologists must approach enough outpatients for clinical care, instructing and training, and examination just as be administered by clinical pros. Their duties to the patients include, yet are not constrained to, examine adverse medication impacts, therapeutics, and cardiovascular risks, perioperative medication and psychopharmacology.
Track 2-1: Bio-pharmaceutics
Track 2-2: Clinical Pharmacology
Track 2-3: Psychopharmacology
Track 2-4: Neuroscience and Pain
Track 2-5: Molecular and Biochemical Pharmacology
Track 3: Clinical Oncology:
Clinical Oncology is a part of medication that manages the prevention, diagnosis, and treatment of malignancy. This study carried out to find innovative ways to treat or prevent the cancer cells by immune responses. Study involves drug delivery system to provide Nano-medicine to induce immune cells. In this type of inducing cells useful for destroying cancer cells not any other healthy cells. For treating cancer cells using chemotherapy, radiotherapy, targeted drug therapy, gene therapy, etc. It will be very effective and less harmful to human health. Clinical Researchers are under the process for treating the cancer cells to enhance the human health.
Track 3-1: Surgical Oncologists
Track 3-2: Radiation Oncologists
Track 3-3: Pathologists
Track 3-4: Hematological-Oncologist
Track 3-5: Pediatric Oncologist
Track 3-6: Gynecologic Oncologist
Track 4: Clinical Cardiology:
Clinical Cardiology is a discipline of medicine that deals with disorders of heart as well as circulatory system. This field includes clinical diagnosis and treatment of inherent heart defects, coronary artery disease, cardiac failure, valvular cardiac illness and electrophysiology. In spite of cardiovascular system is inseparably connected to blood, cardiology usually unconcerned with hematology and its ailments. It may also affect the function of heart would be blood tests, decreased oxygen carrying capacity and coagulopathies. Cardiac drug can affect the function of heart in three main ways such as chronotropic effects, rhythmic effects and inotropic effects. Clinical Researchers finding innovative way for treating cardiac illness without causing any adverse effects for people.
Track 4-1: Adult Cardiology
Track 4-2: Echocardiography
Track 4-3: Interventional Cardiology
Track 4-4: Preventive Cardiology
Track 4-5: Pediatric Cardiology
Track 4-6: Preventive Cardiology
Track 5: Clinical Immunology:
Clinical Immunology is the study of illness caused by disarranges of the immune system has disappointment, atypical activity, and threatening development of the cell components of the system. It includes illness of immune systems plays a vital role in the pathology and clinical features. The disease caused by the immune systems disorders divided into two categories such as immunodeficiency and autoimmunity and other immune system includes various hypersensitivities. In immune system well known disease affects AIDS. Clinical Immunologists study approaches to prevent immune system to destroy allografts.
Track 5-1: Reproductive immunology
Track 5-2: Cancer Immunology
Track 5-3: Diagnostic Immunology
Track 5-4: Theoretical Immunology
Track 5-5: Allergy and Clinical Immunology
Track 6: Novel drug discovery and development:
Drug discovery and development is the field of medicine, biotechnology and pharmacology. Drugs were discovered by recognizing the dynamic ingredient from traditional remedies with penicillin. Chemical libraries of synthetic small atoms, natural products to recognize substance that has a therapeutic effect in classical pharmacology. In sequencing of human genome allowed fast cloning and synthesis of refined proteins, it become regular practice to utilize high throughput screening of large compound against natural targets which are estimated to the infection modifying in process known as reverse pharmacology. From this screens are tried in cells and afterwards creatures for efficacy.
Track 6-1: Drug Target Identification
Track 6-2: Biodegradable polymers
Track 6-3: Proteomics and drug discovery
Track 6-4: Software in clinical drug development and safety
Track 6-5: Complex High-Content Phenotypic Screening
Track 7: Pharmacovigilance:
Pharmacovigilance otherwise called drug protection in the pharmacological science identifying with the assortment, identification, detection and prevention of antagonistic impacts with pharmaceutical products. Accordingly, pharmacovigilance mainly immersion on adverse drug reactions, which are characterized as any reaction to a drug which is harmful and unintended, including absence of adequacy. At last, pharmacovigilance is recognizing about the hazards related with pharmaceutical products and with the limiting the danger of any harm that may come to patients. Organizations must lead an exhaustive medication wellbeing and pharmacovigilance review to evaluate their consistence with overall laws, guidelines and guidance.
Track 7-1: Pharmagenetics
Track 7-2: Pharmagenomics
Track 7-3: Drug monitoring / Methods
Track 7-4: Clinical Trial reporting
Track 7-5: Adverse drug reactions supporting systems
Track 8: Clinical Research versus Clinical Trials:
Clinical Research is a part of medicinal science that decides the wellbeing and viability of drugs, gadgets, symptomatic items and treatment regimens excepted for human use. These might be utilized for avoidance, treatment, finding or calming side effects of a sickness. Clinical Research is not same as clinical practice. In clinical practice built up medicines are utilized, while in clinical exploration proof is gathered to build up a treatment.
Clinical Trials are perceptions done in clinical examinations. Such forthcoming biomedical or research concentrates on human participants are intended to explicit inquiries regarding biomedical or social mediations, including new medicine such as novel immunizations, drugs, dietary enhancements and clinical gadgets known interventions that warrant further investigation and examination.
Track 8-1: Ethical issues in human research
Track 8-2: Protocol development
Track 8-3: Clinical trial design
Track 8-4: Clinical trial monitoring
Track 8-5: Identifying causes of illness
Track 9: Diagnostic Clinical Research:
Diagnostic Clinical Research which includes persons who have signs or symptoms of the illness or condition being investigating. Alludes to clinical trials that are led to discover better tests or systems for diagnosing a specific infection or condition. Similarly, diagnostic clinical research focuses on affectability and particularity of individual diagnostic research tests, their prescient qualities, and different boundaries of absorption. More as of late, there is developing that "test research" concentrated on affectability and particularity isn't really equivalent to "Diagnostic exploration" Modern techniques for indicative exploration center on a procedure by which a patient's test outcome can and ought to be considered with regards to other patient attributes or test outcomes.
Track 9-1: Report on disease outbreak and overcome treatment
Track 9-2: Reporting Hierarchy
Track 9-3: Diagnostic Trials
Track 9-4: Ongoing safety monitoring
Track 9-5: Quality Assurance
Track 10: Ethics in Clinical Research:
Ethics in Clinical Research an arrangement of good rules that can apply qualities to the act of clinical medication and in logical exploration. Clinical ethics depends on a lot of qualities that experts can allude to on account of any disconcerted or struggle. These qualities incorporate the regard for independence, non-perniciousness, value, and justice. Such fundamentals may permit specialists, care suppliers, and families to make a treatment plan and work towards a similar basic goal. It is essential to take note of that these four qualities are not positioned arranged by significance or importance and that they all envelop values relating to clinical ethics.
Track 10-1: Medical Research
Track 10-2: Ethics codes and laws
Track 10-3: Global drug development
Track 10-4: Issues and scientific integrity
Track 10-5: Avoid using deceptive practices
Track 11: Clinical Trials of Drugs:
Clinical Trials of Drugs the researchers examines acted in in people that are planned for assessing a clinical, careful, or social mediation. They are the essential way that scientists see whether another treatment, similar to another medication or diet or clinical gadget is protected and powerful in individuals. Clinical preliminary is utilized to learn if another treatment is progressively powerful as well as has less destructive reactions than the standard treatment.
Other clinical trials test approaches to discover an infection early, in some cases before there are side effects. Still others test approaches to forestall a medical issue. A clinical preliminary may likewise see how to improve life for individuals living with a hazardous sickness or a constant medical issue. Clinical preliminaries in some cases study the job of parental figures or care groups.
Track 11-1: Risk/benefit profile of drugs
Track 11-2: Clinical Trial reporting
Track 11-3: Individual Case Safety Report
Track 11-4: Aggregate Reporting
Track 11-5: Spontaneous reporting
Track 12: Therapeutic and Non-therapeutic Clinical Trial:
Therapeutic Clinical Trials are ones which register patients and give a particular treatment to the patients to consider its effect on disease. In Non-Therapeutic clinical Trials are which don't give a treatment to patients, however rather study significant components which help advance the comprehension of malignancy and its effect. For instance, some non-therapeutic investigations gather tissue examples to look at the cell structure of a malignant growth tumor. Different investigations track epidemiological data similarly, the drawn out wellbeing impacts of chemotherapy. Non-therapeutic examinations frequently lead to helpful ones.
Track 12-1: Real time oncology review
Track 12-2: Novel Trial drug designs
Track 12-3: Chemotherapy
Track 12-4: Prevention and Screening Trials
Track 12-5: supportive and palliative care Trials
Track 13: Pharmacodynamics and Pharmacokinetics:
Pharmacodynamics is the discipline of the biochemical and physiologic impacts of medications in particularly pharmaceutical medications. The impacts can include those showed inside creatures, microorganisms, or combined of living beings. Pharmacodynamics and pharmacokinetics are simply the primary parts of pharmacology, being a subject of science involved by the investigation of the associations between both endogenous and exogenous compound substances with living beings. Pharmacokinetics is a part of pharmacology the destiny of substances regulated to a living life form. The substance of absorption include any synthetic xenobiotic like pharmaceutical medications, pesticides, food added substances and so forth. Pharmacokinetics is the investigation of how a creature influences a medication, though pharmacodynamics is the investigation of how the medication influences the living being.
Track 13-1: Ecotoxicology
Track 13-2: Multicellular pharmacodynamics
Track 13-3: Toxicodynamics
Track 13-4: Pharmacogenetics
Track 13-5: Pharmacogenomics
Track 14: Clinical Trial Protocol:
Each clinical examination starts with the advancement of a clinical protocol. The protocol is an archive that depicts how a clinical preliminary will be led the objective, structure, technique, factual contemplations and association of a clinical preliminary, and guarantees the wellbeing of the preliminary subjects and trustworthiness of the information gathered. A Clinical research protocol is an archive that depicts the foundation, reason, destinations, plan, strategy, factual contemplations, and association of a clinical examination project.
Track 14-1: Study goals and objectives
Track 14-2: Methodology
Track 14-3: Safety considerations
Track 14-4: Rationale & background information
Track 14-5: Study design
Track 15: Clinical Toxicology:
Clinical Toxicology is a discipline of science that deals with biology, pharmacology and medication that includes the investigation of the adverse impacts of synthetic substances on living organisms and the act of diagnosing and getting exposures poisons and toxicants. The connection among dose and its consequences on the exposed creatures to toxins and toxicants. Toxicologists are experts on poisons and poisoning. There is a movement for clinical toxicology as part of the larger movement towards clinical-based practices. In clinical toxicology endeavors to transparently, reliably, and objectively evaluate accessible to respond in inquiries of toxicology.
Track 15-1: Molecular Toxicology
Track 15-2: Biomedical Toxicology
Track 15-3: Aquatic Toxicology
Track 15-4: Applied Toxicology
Track 15-5: Forensic Toxicology
Track 16: Pharmacology in Clinical Practice:
Pharmacology in Clinical Practice describes fundamental pharmacology, clinical pharmacology and including the significant of pharmacology medication gatherings. Clinical pharmacology including drug activities, absorption and excreted. Most medications are xenobiotic mixes outside and destructive to human living tissues. Medications ought to be appropriately utilized and changed over to nontoxic substance before being excreted either through unconstrained changes not interceded by compounds or through change by chemical frameworks. It also includes pharmacogenetics that manages with various responses to drug inhale because of elements such as renal sickness, smoking, and diet.
Track 16-1: Clinical Pharmacy Practice
Track 16-2: Cardiovascular Immunobiology
Track 16-3: Drug Discovery Pharmacology
Track 16-4: Pulmonary Pharmacology
Track 16-5: Lung Biology
Track 17: Pharmacognosy:
Pharmacognosy is a part of drug that reviews plants or other normal sources as a potential wellspring of medications. It includes analysis of their organic, compound, biochemical and physical properties. Plants and life forms are utilized in an assortment of routes in the creation of traditional and elective medications. The helpful dynamic element of the plant might be found anywhere in its physical structure, for example, in the petal or stem of a blossom. The regular item may be latent in its standard physical structure, so it might take a substance response or alteration to bring it into its dynamic structure. Now and again, the dynamic fixing is removed legitimately from the plant, however on different events the dynamic fixing can be delivered by means of blend by making an exacerbate that acts likewise to the plant separate.
Track 17-1: Ethnopharmacology
Track 17-2: Zoopharmacognosy
Track 17-3: Marinepharmacognosy
Track 17-4: Phytochemistry
Track 17-5: Ethnobotany
Track 18: Radiopharmacology:
Radiopharmacology is a part of radiochemistry that has been applied to medication. Radiopharmaceuticals are utilized in the field of atomic medication as radioactive tracers in clinical imaging and in treatment for some sicknesses. Numerous radiopharmaceuticals use technetium-99m which has numerous helpful properties as a gamma-radiating tracer nuclide. Technetium a sum of 31 unique radiopharmaceuticals dependent on Tc-99m are recorded for imaging and useful investigations of the mind, myocardium, thyroid, lungs, liver, gallbladder, kidneys, skeleton, blood and tumors.
Track 18-1: Radionuclide
Track 18-2: Radiopharmaceutical
Track 18-3: Radioisotopes
Track 18-4: Radioactive Tracer
Track 18-5: Radiocompounds
Track 19: Clinical Dermatology:
Clinical Dermatology is a discipline of medicine managing with the skin. It deals with both clinical and surgical aspects. A dermatologist is an authority specialist who oversees sickness identified with skin, hair and nails and some restorative problems. Clinical Research did so as to discover new conventional drugs and definitions for the ailments related with skin, hair, and nails are named as test dermatology. It manages the clinical and trial clinical examination completed to show signs of improvement, more intelligent and feasible excellence and wellbeing items.
Track 19-1: Cosmetic dermatology
Track 19-2: Dermatopathology
Track 19-3: Immunodermatology
Track 19-4: Teledermatology
Track 19-5: Dermatoepidemiology
Track 20: Clinical trials on infectious diseases:
Clinical trials on infectious diseases and clutters are driver for surveying in any event one prescription for example drugs, helpful devices, and approaches to manage medical procedure or radiation treatment for rewarding an illness, issue, or condition besides finding ways to deal with keep the basic headway or rehash of an affliction or condition. These can fuse drugs, vaccinations, or lifestyle changes, among various systems.
Track 20-1: Anesthesiology research
Track 20-2: Diabetes research
Track 20-3: General clinical research information
Track 20-4: Craniofacial disorders research
Track 20-5: Cochlear implant technology research
The worldwide clinical trials market size is relied upon to reach USD 69.9 million by 2027, as per another report by Grand View Research. It is anticipated to display a CAGR of 5.1% during the conjecture time frame. Clinical preliminaries have become progressively exorbitant endeavors, adding to the general expense of building up a medication. Thus, large pharmaceuticals just as little biotechnology firms are searching for inventive approaches to improve preliminary results and decline preliminary expenses.
In European country the clinical trials market size was reached at USD 4.62 million and it will be reach up to USD 6.51 million by the year of 2024 at a CAGR 7.10% from the year 2019 to 2024. In Europe clinical trial market has been growing rapidly. In current situation COVID-19 is pandemic and it is highly influencing clinical trials in Europe.
The maximum number of peoples affecting with COVID-19 is extremely high, which is a central point for the market to develop. Italy is one of the most noticeably awful COVID-19 flare-ups on the world. Spain is also influenced because of this pandemic and is set up the interest of the market. France was chief leading in the market; however current difficulties to run clinical preliminaries securely and successfully are impeding the clinical preliminaries market development in this locale. Government, industry and associations are working together to develop an antibody to against COVID-19.
UK is one of the main countries in examination of coronary illness, immunology and sensory system. UK government has propelled another clinical preliminary program to quick track the improvement of new medications to treat COVID-19 named ACCORD. Germany is profoundly occupied with innovative work; over 70% of clinical preliminaries have support from the government association. In Germany has started the research work Phase I/II clinical trials to treat COVID-19. Spain began another treatment, for example, Phase II clinical preliminary of a medication named Aplidin to treat COVID-19. In France clinical preliminaries of Ivermectin to treat COVID-19.